If you or someone you know has been diagnosed with early Alzheimer’s disease, you might be interested in the Janssen Autonomy Study. This study is examining if JNJ-63733657, an Anti-tau Monoclonal Antibody, will show cognitive improvement in participants with Alzheimer’s Disease.
There is no cost to participate. Participants will receive all study-related care from a research doctor at no cost, and may be compensated per study site visit for time and travel expenses.
Who can join the Janssen Autonomy Study?
You may be able to take part if you:
– are 55-80 years of age
– have had gradual and progressive memory loss for 6 months
– have a family member or close friend who is with you at least 10 hours per week and can attend study appointments with you